How many insider trades does FilingIQ track for GALT?

FilingIQ tracks 637 Form 4 insider transactions for GALT (GALECTIN THERAPEUTICS INC), covering filings from Mar 12, 2015 onwards. 1 of those were filed in the last 90 days.

Are GALT insiders net buyers or net sellers?

Across the full Form 4 history for GALT, 109 transactions (17%) were open-market purchases and 167 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GALT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is GALT in?

GALECTIN THERAPEUTICS INC (GALT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $188.28M.

GALT insider trading

NasdaqCM Healthcare

GALECTIN THERAPEUTICS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

637

Last 90 days

Buys / sells

17% / 26%

Market cap

$188.28M

About GALECTIN THERAPEUTICS INC

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Company website: galectintherapeutics.com

GALT insider activity at a glance

FilingIQ has scored 637 insider transactions for GALT since Mar 12, 2015. The most recent filing in our index is dated Mar 12, 2026.

Across the full history, 109 open-market purchases and 167 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GALT insider trades is 53.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live GALT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for GALT?: FilingIQ tracks 637 Form 4 insider transactions for GALT (GALECTIN THERAPEUTICS INC), covering filings from Mar 12, 2015 onwards. 1 of those were filed in the last 90 days.
Are GALT insiders net buyers or net sellers?: Across the full Form 4 history for GALT, 109 transactions (17%) were open-market purchases and 167 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GALT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is GALT in?: GALECTIN THERAPEUTICS INC (GALT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $188.28M.

Methodology & sources

Every GALT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.